Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT03637257
Other study ID # UKBB_Anae_CO2_Gued_Feas
Secondary ID
Status Withdrawn
Phase N/A
First received
Last updated
Start date November 2020
Est. completion date January 2021

Study information

Verified date November 2020
Source University Hospital, Basel, Switzerland
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This trial compares capnographic signals using a modified CO2/O2 Guedel airway with a CO2/O2 nasal cannula without and with oxygen supply in sedated children aged 4 - 24 months.


Description:

Sedation of pediatric patients is frequently jeopardized by respiratory adverse events such as central and/or obstructive apnea resulting in hypoxemia. Various factors such as patient comorbidities, medication and inconsistent physiologic monitoring are known to contribute to or facilitate adverse events during sedation. Therefore, monitoring of breathing by capnography is recommended and has become common standard e.g. by the use of a CO2/O2 nasal cannula. However, capnography derived from CO2/O2 nasal cannulas may be impaired and these impairments are exaggerated in infants based on their physiologic characteristics (small tidal volumes, high respiratory rates). To overcome these impairments, the investigators developed a modified CO2/O2 Guedel airway including a CO2 sampling port at the tip of the airway. In a previous study, significantly more accurate capnographic signals resulted compared with measurements derived from a nasal cannula when using a modified CO2/O2 Guedel airway in a model of a breathing 6-month-old manikin. The aim of the study is to examine the accuracy of capnographic measurements of the modified CO2/O2 Guedel airway in comparison with measurements from a CO2/O2 nasal cannula in sedated children aged 4 - 24 months.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date January 2021
Est. primary completion date January 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 4 Months to 24 Months
Eligibility Inclusion Criteria: - Term born infants aged 4 to 24 months - Physical status according classification I or II (American Society of Anaesthesiologists (ASA)) - Scheduled for elective diagnostic/therapeutic procedures or surgery under sedation/anaesthesia - Informed Consent as documented by signature of the parents or legal caregiver Exclusion Criteria: - syndrome that affects the airway anatomy - Physical status according classification III or IV (American Society of Anaesthesiologists (ASA)) - Upper respiratory tract infection at present or within the last two weeks before the study - Previous enrolment into the current study - Known hypersensitivity or allergic reactions to midazolam, nitrous oxide (N2O), Propofol or Sevoflurane. - Positive Family History for malignant hyperthermia, Morbus Pompe or ophthalmic operations with gas injection or Sinus- or inner ear surgery.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
modified Guedel airway
Monitoring of breathing

Locations

Country Name City State
Switzerland University Children´s Hospital Basel Basel Stadt

Sponsors (2)

Lead Sponsor Collaborator
University Hospital, Basel, Switzerland University Children's Hospital Basel

Country where clinical trial is conducted

Switzerland, 

References & Publications (1)

Moll J, Anagnostopoulou P, Frei FJ, Erb TO. A modified CO2/O2 Guedel airway improves capnographic accuracy compared with a CO2/O2 nasal cannula: An infant manikin study. Eur J Anaesthesiol. 2018 Aug;35(8):566-572. doi: 10.1097/EJA.0000000000000818. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary end-tidal carbon-dioxide concentration (etCO2) Difference between capillary and maximum etCO2 sampled via a modified CO2/O2 Guedel airway versus a CO2/O2 nasal cannula 90 seconds
Secondary Change of end-tidal carbon-dioxide concentration (etCO2) according to different oxygen flows (O2) Effect of O2 administration on etCO2 measurement 90 seconds